Profil
Marta Vlatchkova currently works at SGS SA, as Chief Financial Officer from 2024.
Ms. Vlatchkova also formerly worked at Sandoz Group AG, as Chief Accounting Officer from 2023 to 2024, EssilorLuxottica SA, as Head-Group Financial Planning & Analysis, and Holcim Ltd. (Switzerland), as Group Head-Accounting & Reporting from 2018 to 2023.
Ms. Vlatchkova received her undergraduate degree from the University of National & World Economy.
Postes actifs de Marta Vlatchkova
| Sociétés | Poste | Début |
|---|---|---|
| SGS SA | Directeur Financier/CFO | 08/05/2024 |
Anciens postes connus de Marta Vlatchkova
| Sociétés | Poste | Fin |
|---|---|---|
| SANDOZ GROUP AG | Comptroller/Controller/Auditor | 01/05/2024 |
Holcim Ltd. (Switzerland)
Holcim Ltd. (Switzerland) Construction MaterialsNon-Energy Minerals Manufactures cement, aggregates, concrete and construction related materials | Comptroller/Controller/Auditor | 01/01/2023 |
| ESSILORLUXOTTICA | Corporate Officer/Principal | - |
Formation de Marta Vlatchkova
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
EssilorLuxottica SA
EssilorLuxottica SA Medical SpecialtiesHealth Technology Manufactures, distributes and retails eyewear, ophthalmic lenses, frames & sunglasses | Health Technology |
Holcim Ltd. (Switzerland)
Holcim Ltd. (Switzerland) Construction MaterialsNon-Energy Minerals Manufactures cement, aggregates, concrete and construction related materials | Non-Energy Minerals |
SGS SA
SGS SA Miscellaneous Commercial ServicesCommercial Services Provides testing, inspection and certification services | Commercial Services |
University of National & World Economy
University of National & World Economy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sandoz Group AG
Sandoz Group AG Pharmaceuticals: MajorHealth Technology Manufactures medicines and biosimilars | Health Technology |
















